Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion


New Delhi: US-based Coca-Cola Co, is within the race to accumulate malt-based well being drink Horlicks from GlaxoSmithKline (GSK), which has put the favored model in India on sale, in line with media reviews.

Quoting sources, UK-based Sunday Telegraph has mentioned the worth of the transaction might be round three billion British kilos ($3.9 billion).

The corporate “is mulling a 3 billion British kilos ($3.9 billion) swoop for Horlicks after GlaxoSmithKline (GSK) hoisted a ‘on the market’ signal above the 145-year-old model,” the report mentioned.

Representational picture. AP

It additional mentioned that moreover Coca-Cola, a number of world FMCG makers as Nestle, Kraft Heinz are within the race to accumulate Horlicks from GSK.

“As a matter of coverage we don’t touch upon any speculative information. At this time limit there’s nothing to report on the mentioned matter,” CocaCola mentioned in an e-mail assertion.

The Atlanta-based cola main had acquired the Costa Espresso chain from UK-based leisure group Whitbread in a $5 billion deal just lately.

If the deal occurs, then this may be second main acquisition by Coca-Cola within the Indian market, when it had re-entered into the Indian market after shopping for then fashionable manufacturers corresponding to Thums Up, Limca and Gold Spot.

Horlicks in India is essentially offered via GlaxoSmithKline Healthcare, through which GSK owns 72.5 % stake.

GSK has put Horlick on the blocks after it had determined to purchase 36.5 % stake within the shopper healthcare enterprise of Novartis for 9.2 billion British kilos.

The corporate is contemplating to promote Horlicks and different diet manufacturers to fund the acquisition.



Source link